Status:

COMPLETED

The Second Multicenter Hemophilia Cohort Study

Lead Sponsor:

National Cancer Institute (NCI)

Collaborating Sponsors:

Multicenter Hemophilia Cohort Study

Conditions:

Liver Decompensation

Hepatocellular Carcinoma

Eligibility:

All Genders

13+ years

Brief Summary

The Second Multicenter Hemophilia Cohort Study (MHCS-II) will evaluate and prospectively follow approximately 4500 persons with hemophilia who were exposed to hepatitis C virus (HCV). The vast majorit...

Detailed Description

The Second Multicenter Hemophilia Cohort Study (MHCS-II) will evaluate and prospectively follow approximately 4500 persons with hemophilia who were exposed to hepatitis C virus (HCV). The vast majorit...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Must be registered patient with an inherited coagulation disorder at a participating MHCS-II center. Disorders include hemophilia A or B (congenital factor VIII or IX deficiency), deficiencies in other factors such as V or XI, and vonWillebrand's disease. (Unless noted otherwise, all of the disorders will collectively be referred to as hemophilia .) All such hemophilia and vonWillebrand s disease patients are to be recruited as study participants.
  • Since January 1, 1993, must have had at least one positive result on a licensed assay for HCV antibodies, HIV antibodies, or HIV RNA.
  • Must be at least 13 years of age at enrollment.
  • Must provide signed informed consent or, for minors, signed assent plus signed informed consent from the parent or guardian.
  • EXCLUSION CRITERIA:
  • Is not a patient with an inherited coagulation disorder.
  • Does not have a positive test for HCV antibodies, HIV antibodies, or HIV RNA on a licensed assay performed since January 1, 1993.
  • Is less than 13 years of age.
  • Lacks informed consent/assent.

Exclusion

    Key Trial Info

    Start Date :

    April 27 2001

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    April 2 2013

    Estimated Enrollment :

    2565 Patients enrolled

    Trial Details

    Trial ID

    NCT00341705

    Start Date

    April 27 2001

    End Date

    April 2 2013

    Last Update

    December 17 2019

    Active Locations (48)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 12 (48 locations)

    1

    University of Arizona

    Tucson, Arizona, United States, 85724

    2

    University of California, Davis

    Davis, California, United States, 95616

    3

    Children's Hospital of Orange County

    Orange, California, United States, 92613

    4

    University of California, San Francisco

    San Francisco, California, United States, 94143